Development and Validation of a Comprehensive Standardised Clinical Assessment Tool for Patient Needs
NCT ID: NCT02778347
Last Updated: 2016-05-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
480 participants
OBSERVATIONAL
2013-09-30
2017-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Elaboration of a Multi-dimensional Indicator of Quality in Palliative Care
NCT02814682
Cancer End Of Life Evaluation
NCT01545921
Assessment of the Reasons for Accepting or Refusing Early Palliative Care
NCT04717440
Advance Care Planning in Palliative Care
NCT05662917
Effect of Early Palliative Care on Quality of Life of Patients With Advanced Cancer: a Randomised Controlled Trial.
NCT01865396
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In France, around 150000 people require palliative care every year. Since 2002, palliative care has been organized at several levels: palliative care units, palliative care mobile support teams, health network for palliative care and home-based hospital care. These structures have made possible for some patients in need of palliative care to be treated in appropriate service, in facility-based or community-based programs. With these important advances around palliative care, it appears important to assess the quality of care provided to patients. However, no generalizable study has been conducted in France, and no formal tool is available to help at this end.
In order to enhance the effectiveness of these services, it is important to conduct studies with the aim of developing the adapted and standardized tools that will enable assessment of quality for palliative care, as well as its determinants, for example the organization of structures, management of teams, etc. To this end, it is relevant to adopt a more holistic perspective and take into account the views of different concerned people, including the patients, their families and healthcare professionals, all while considering the organizational and management aspects.
The evidence from other countries has demonstrated the necessity of a rigorous, exhaustive and systematic evaluation as a requirement for any palliative program of quality. Many tools have since been developed to assess the multidimensional needs of patients, but none of these tools have been adapted to be used in the French palliative care settings.
Among of different tools used in palliative care, InterRAI Palliative Care (RAI-PC) has been chosen as the most reliable and complete tool. The RAI-PC allows a comprehensive evaluation of patients, as well as capabilities, preferences and needs. The medical, psychological, functional and social indicators are defined. This tool has been applied in the palliative care field in Canada and USA, but not yet in France. It has proven itself as an appropriate tool for needs assessment and evaluation of quality of care.
Goals of the project
This project aims to develop and validate a comprehensive and standardized instrument that will serve:
1. As a support to individual care, emphasizing the individual characteristics and needs of patients, informing planning care, outcome measurement, quality indicators, and case-mix classification.
2. As a standardized assessment tool adaptable to various palliative care structures
Study design
This study is a multicenter, prospective, observational study with representative stratified sample from different categories of palliative care services: palliative care units, palliative care mobile support teams, health network for palliative care and home-based hospital care. Twenty-three palliative structures, spread across the country are participating in this project.
The survey will involve the healthcare professionals of each center, trained on collecting information and using InterRAI instrument. Data collection involves patient clinical assessment, reviewing medical and nurse record and interview with family and professionals of healthcare.
Criteria for judgement
The quality of the tool will be judged in terms of satisfactory of psychometric properties, operational characteristics and clinical acceptability, adaptability of the tool to the needs of patients and its relevance in different palliative care structures.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients receiving palliative care at home or in hospital at the time of screening
Exclusion Criteria
* Patient waiting a transfer within 48 hours
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ministère de la Santé
UNKNOWN
Unité de Recherche Clinique Paris-Ouest
UNKNOWN
Maison Médicale Jeanne Garnier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Maison Médicale Jeanne Garnier
Paris, Paris, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12-002-0105
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.